MDevSPICE - A comprehensive solution for manufacturers and assessors of safety-critical medical device software by Clarke, Paul et al.
A. Mitasiunas et al. (Eds.): SPICE 2014, CCIS 477, pp. 274–278, 2014. 
© Springer International Publishing Switzerland 2014 
MDevSPICE - A Comprehensive Solution  
for Manufacturers and Assessors of Safety-Critical 
Medical Device Software  
Paul Clarke, Marion Lepmets, Fergal McCaffery, Anita Finnegan,  
Alec Dorling, and Derek Flood 
Regulated Software Research Centre, Dundalk Institute of Technology,  
Dundalk, Ireland 
{paul.clarke,marion.lepmets,fergal.mccaffery, 
anita.finnegan,alec.dorling,derek.flood}@dkit.ie 
Abstract. Software development is frequently challenged with quality 
concerns. One of the primary reasons for such issues is the very nature of the 
software development process. First, it can be difficult to accurately and 
completely identify the requirements for a software development product. Also, 
the implementation on various platforms and the need to integrate with 
sometimes unforeseeable additional systems adds complexity. For safety critical 
domains, such as the medical device and healthcare sectors, these hurdles are 
amplified. Whereas a failure in a desktop application may be resolved through a 
restart with no harm incurred, a failure in a medical device can have life 
threatening consequences. Our work in the Regulated Software Research Centre 
(RSRC) aims to support medical device producers in the production of safer 
medical device software. In this paper, we describe the MDevSPICE framework 
and how it addresses the safety concerns faced by medical device producers.  
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Device Software Process Assessment and Improvement, MDevSPICE. 
1 Introduction 
As software is increasingly incorporated into medical devices, so too is there a 
growing need to address the potential harm that can be caused by faulty software.  
As recently as 2011, “software failures were behind 24% of all the medical device 
recalls” FDA [1]. While the medical device domain is controlled by regulations that 
are designed to promote safety, the regulation is in practice satisfied through the 
implementation of appropriate process and quality standards. In recent years, a 
significant number of new or extended medical device software standards and 
guidance has emerged, with the result that we now have a large body of often 
disparate information on how best to implement medical device software.  
This circumstance gives rise to a number of issues. Firstly, with the information 
originating from different sources, it is expensive and difficult for manufacturers to 
determine the scope of each source, and more difficult still to accurately determine 
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the overlap and distinction between the sources. Secondly, competent authorities are 
also challenged to stay in tune with the emerging standards and guidelines in a 
domain that traditionally had a much smaller software footprint. Thirdly, the task of 
both manufacturers and competent authorities is further complicated by the absence of 
a consistent, internationally recognized and authoritative framework for assessing the 
manufacturers to deliver robust and reliable software to the medical device sector.  
To address these issues, researchers in the RSRC have developed an internationally 
recognized framework hand-in-hand with the international standards organisations 
that consolidates the disparate medical device best practices into a single framework: 
MDevSPICE (formerly known as MediSPICE). Furthermore, the MDevSPICE 
framework is leveraged on leading generic software engineering best practice 
frameworks, and provides for a consistent and repeatable method for evaluating the 
competency of medical device software developers.  
2 Medical Device Regulation and Standards 
A medical device can consist wholly of software or have software as a component of 
the overall device [2]. In order to market a medical device within a given jurisdiction, 
it is necessary that the device complies with the regulatory demands of that region. 
The two largest global bodies involved in the development and evolution of medical 
device regulation are the Food and Drug Administration (FDA) and the European 
Commission (EC).  
In the case of the US, the FDA issues the relevant regulation through a series of 
formal channels, including the Code of Federal Regulation (CFR) Title 21, Chapter I, 
Subchapter H, Part 820 [3] (ref. Figure 1). In the EU, the regulation is outlined in a 
number of sources: Medical Device Directive (MDD) 93/42/EEC [2], Active 
Implantable Medical Device Directive (AIMDD) 90/385/EEC [4], and In-vitro 
Diagnostic (IVD) Medical Device Directive 98/79/EC [5] – with all of these being 
amended by MDD 2007/47/EC [6]. Both the US and EU regulations outline varying 
degrees of safety concerns dependent on the medical device classification, which is 
broadly similar in both jurisdictions, ranging from Class I devices that are not 
intended to support or sustain human life, to Class III devices which have a critical 
role to play in supporting life.  
The regulation outlined in the previous paragraphs may be satisfied through the 
implementation of medical device guidance and standards. ISO 13485:2003 (ISO 
13485 from hereon) [7] outlines the requirements for regulatory purposes from a 
Quality Management System (QMS) perspective. ISO 13485, which is based on ISO 
9001 [8], can be used to evaluate an organisation’s ability to meet both customer and 
regulatory requirements. However, ISO 13485 does not offer specific guidance on 
software development, a role that is filled by IEC 62304:2006 (IEC 62304 from 
hereon) [9] which outlines the lifecycle processes necessary for the safe design and 
maintenance of medical device software. Beyond IEC 62340, numerous additional 
standards and guidance documents exist, such as ISO/IEC 12207:2008 and ISO/IEC 
15504-5:2012 (ref. Figure 1) and these have been integrated into the MDevSPICE 
framework. In Figure 2, we provide an overview of the primary standards and sources 
of best practice that have been incorporated into the MDevSPICE solution. With all of 
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the acknowledged best practice and guidance for medical device software 
development now housed within a single framework, it is possible to assess medical 
device software development to the most rigourous level. This MDevSPICE 
framework can be adapted and extended as the underlying standards and guidance 
evolve, thus ensuring that by adopting the MDevSPICE solution, organisations and 
assessment bodies can be confident that no key items have been overlooked. 
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Fig. 1. Medical Device Regulations and Standards 
In developing MDevSPICE significant international standards engagement has 
been required, with IEC TR 80002-3 (Process Reference Model for IEC 62304) now 
published [10]. IEC TR 80002-3 represents the culmination of many years of 
dedicated work by the RSRC, creating important new standards within the working 
 MDevSPICE - A Comprehensive Solution for Manufacturers and Assessors 277 
groups of both the ISO and the IEC. Work of this nature also established a solid 
international agreement on the contributions made by the RSRC. Through working 
with international standards working groups such as IEC SC62A/ JWG3, IEC 
SC62A/JWG7 and ISO/IEC JTC1 SC7 WG10, the RSRC has advanced other 
standards, including IEC 80001-1-7 (Process Assessment Model for IEC 80001-1) 
and IEC 80001-2-8 (Guidance on standards for establishing Security Capabilities 
identified in IEC/TR 80001-2-2). 
 
Fig. 2. MDevSPICE Process Assessment. 
MDevSPICE itself is scheduled to be brought to the global market in Q4.2014 and 
it will for the first time concentrate the accumulated medical device best practices 
from all leading sources, while also supporting the industry and regulators in 
consistently and accurately evaluating software process implementation. This is good 
news for regulators, as a robust and thorough framework grounded in international 
standards will exist for assessing medical device software producers. And it is good 
news for the producers too, as all the medical device know-how will for the first time 
be assembled in a single, authoritative framework. 
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